The report “Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019”

The global pharmacovigilance and drug safety software market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $154.1 Million in 2019.

Browse 74 market data tables and 57 figures spread through 210 pages and in-depth TOC on“ Pharmacovigilance and Drug Safety Software Market “
http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html
Early buyers will receive 10% customization on this reports.

The global pharmacovigilance and drug safety software market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $154.1 Million in 2019.

Download PDF Brochure :http://www.marketsandmarkets.com/pdfdownload.asp?id=16831714

In this report, the global pharmacovigilance and drug safety software market has been classified into many segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software.

The global pharmacovigilance and drug safety software market is divided into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other
pharmacovigilance service providers.

Download Request Sample : http://www.marketsandmarkets.com/requestsample.asp?id=16831714

ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.) are some of the key players in the global pharmacovigilance and drug safety software market.

As of 2014, North America holds the largest share of the global pharmacovigilance and drug safety software market, followed by Europe.

However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.